RxDoctor Payments Data

Joseph Richardson, DO

Family Medicine · Gate City, VANPI 1386140135

Payments from drug & device makers

$323in general payments, 2019–2025

Across 19 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$106
  • AstraZeneca$57
  • Bayer$54
  • Inogen, Inc.$46
  • Novo Nordisk$43
  • Irhythm Technologies, Inc.$18

What the payments were for

  • Food & beverage$323100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amarin Pharma, Inc.5$106
AstraZeneca4$57
Bayer3$54
Inogen, Inc.3$46
Novo Nordisk3$43
Irhythm Technologies, Inc.1$18

How this compares

$323 in reported general payments places this provider in the 50th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$97,765
Medicare patients
110
Services billed
3,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban205$173,895
OzempicSemaglutide63$103,909
XifaxanRifaximin24$85,507
JanuviaSitagliptin Phosphate38$54,276
JardianceEmpagliflozin51$49,548
TrulicityDulaglutide25$42,419
FarxigaDapagliflozin Propanediol17$21,296
LinzessLinaclotide27$16,284
XareltoRivaroxaban17$15,786
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$11,702
SymbicortBudesonide/Formoterol Fumarate24$9,511
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$9,161
EntrestoSacubitril/Valsartan12$9,124
Tresiba Flextouch U-100Insulin Degludec17$8,627
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen264$7,036

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$43$103,90963 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$57$39,96856 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Gate City

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →